palbociclib: Clinical Trials

4 completed. 4 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	4	Completed 4

Follow palbociclib: new trials by email Literature Review of palbociclib trials Research Report on palbociclib

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt Palbocicilib, Ribociclib, Abemaciclib - Breast Cancer	Phase 4	Completed	Beni-Suef University	206	2024-08-25	2026-03-23
Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg Palbociclib 125mg - Bioequivalence	Phase 4	Completed	Megalabs	24	2024-02-06	2024-08-19
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel, vinorelbine) / Endocrine therapy (exemestane, fulvestrant, letrozole, tamoxifen) - Metastatic Breast Cancer	Phase 4	Completed	GBG Forschungs GmbH	130	2018-03-01	2024-10-01
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer Palbociclib, Letrozole - Breast Cancer	Phase 4	Completed	Pfizer	252	2016-03-09	2022-07-27

Conditions studied

Breast Neoplasms (3)  ·  Patient Acceptance of Health Care (1)

Sponsors

Beni-Suef University (1)  ·  GBG Forschungs GmbH (1)  ·  Megalabs (1)  ·  Pfizer (1)

Countries

India (2)  ·  Australia (1)  ·  Egypt (1)  ·  Germany (1)

Top investigators

M Gowtham, MD (1)  ·  Sibylle Loibl, MD, PhD (1)

NIH funding

2016 (1)